Desong Kong

2.4k total citations · 2 hit papers
51 papers, 1.8k citations indexed

About

Desong Kong is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Desong Kong has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 23 papers in Hepatology and 14 papers in Molecular Biology. Recurrent topics in Desong Kong's work include Liver physiology and pathology (22 papers), Liver Disease Diagnosis and Treatment (21 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Desong Kong is often cited by papers focused on Liver physiology and pathology (22 papers), Liver Disease Diagnosis and Treatment (21 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Desong Kong collaborates with scholars based in China, United States and Germany. Desong Kong's co-authors include Shizhong Zheng, Zili Zhang, Jiangjuan Shao, Yin Lu, Feng Zhang, Li Chen, Shanzhong Tan, Mei Guo, Feng Zhang and Yujia Li and has published in prestigious journals such as Hepatology, Scientific Reports and Journal of Cell Science.

In The Last Decade

Desong Kong

50 papers receiving 1.7k citations

Hit Papers

RNA-binding protein ZFP36/TTP protects against ferroptosi... 2019 2026 2021 2023 2019 2023 100 200 300

Peers

Desong Kong
Fausto Andreola United Kingdom
Wenhui Mo China
Zhi Dai China
Yuqin Yao China
Desong Kong
Citations per year, relative to Desong Kong Desong Kong (= 1×) peers Shanzhong Tan

Countries citing papers authored by Desong Kong

Since Specialization
Citations

This map shows the geographic impact of Desong Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desong Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desong Kong more than expected).

Fields of papers citing papers by Desong Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desong Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desong Kong. The network helps show where Desong Kong may publish in the future.

Co-authorship network of co-authors of Desong Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Desong Kong. A scholar is included among the top collaborators of Desong Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desong Kong. Desong Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qingrui, Hao Chen, Shujun Jiang, et al.. (2025). Progressively altered genes in colorectal carcinogenesis link oncogenesis immune cycle and tumor microenvironment. Scientific Reports. 15(1). 37495–37495.
2.
Hong, Chunlan, Shuo Huang, Jiang Qiu, et al.. (2024). An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway. Phytomedicine. 132. 155658–155658. 13 indexed citations
3.
Xu, Yanyan, et al.. (2024). Progress in the Application of Organoids-On-A-Chip in Diseases. Organogenesis. 20(1). 2386727–2386727. 6 indexed citations
4.
Xu, Yanyan, et al.. (2024). The Potential Mechanism of the Anti-Liver Fibrotic Effect of Curcumin in the Gut-Liver Axis. Journal of Medicinal Food. 27(5). 404–418. 2 indexed citations
5.
6.
Chen, Li, Siwei Xia, Feixia Wang, et al.. (2023). m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis. Pharmacological Research. 189. 106704–106704. 18 indexed citations
7.
You, Juping, et al.. (2023). The Efficacy and Mechanism of Qinghua Jianpi Recipe in Inhibiting Canceration of Colorectal Adenoma Based on Inflammatory Cancer Transformation. Journal of Immunology Research. 2023. 1–19. 2 indexed citations
8.
Wang, Yi, Tong Zhao, Fei Liu, et al.. (2023). Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach. Phytomedicine. 123. 155174–155174. 25 indexed citations
9.
Wu, Xiaoqian, et al.. (2022). The application of omics techniques to evaluate the effects of Tanshinone IIA on dextran sodium sulfate induced ulcerative colitis. Molecular Omics. 18(7). 666–676. 6 indexed citations
10.
Han, Wei, Desong Kong, Qin Lu, Wei Zhang, & Zhimin Fan. (2021). Aloperine inhibits colorectal cancer cell proliferation and metastasis progress via regulating miR-296-5p/STAT3 axis. Tissue and Cell. 74. 101706–101706. 8 indexed citations
11.
Wang, Yi, Wang Wang, Fang Shang, et al.. (2021). Untargeted GC-MS-Based Metabolomics for Early Detection of Colorectal Cancer. Frontiers in Oncology. 11. 729512–729512. 22 indexed citations
12.
Chen, Liping, Ling Wang, Zili Zhang, et al.. (2020). The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism. Expert Review of Gastroenterology & Hepatology. 14(4). 259–270. 17 indexed citations
13.
Han, Wei, et al.. (2020). Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR‐409‐3p. Evidence-based Complementary and Alternative Medicine. 2020(1). 8394574–8394574. 30 indexed citations
14.
Chen, Lianyun, Qin Chen, Yifeng Cheng, et al.. (2016). Diallyl trisulfide attenuates ethanol-induced hepatic steatosis by inhibiting oxidative stress and apoptosis. Biomedicine & Pharmacotherapy. 79. 35–43. 40 indexed citations
15.
Chen, Qin, Lianyun Chen, Desong Kong, et al.. (2016). Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-βR/ERK signaling pathway. International Immunopharmacology. 34. 250–258. 42 indexed citations
16.
Chen, Lianyun, Qin Chen, Xiaojing Zhu, et al.. (2016). Diallyl trisulfide protects against ethanol-induced oxidative stress and apoptosis via a hydrogen sulfide-mediated mechanism. International Immunopharmacology. 36. 23–30. 45 indexed citations
17.
Kong, Desong, Feng Zhang, Jiangjuan Shao, et al.. (2015). Curcumin inhibits cobalt chloride-induced epithelial-to-mesenchymal transition associated with interference with TGF-β/Smad signaling in hepatocytes. Laboratory Investigation. 95(11). 1234–1245. 52 indexed citations
18.
Li, Xiang, et al.. (2014). Research progress on pathogenesis of alcoholic liver disease. 30(2). 160–163. 2 indexed citations
19.
Zhang, Feng, Zili Zhang, Desong Kong, et al.. (2013). Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways. Molecular and Cellular Endocrinology. 382(1). 197–204. 44 indexed citations
20.
Chen, Li, Feng Zhang, Desong Kong, et al.. (2013). Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: A potential mechanism of hepatotoxicity. Chemico-Biological Interactions. 206(1). 76–82. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026